Roberto Solari
Private Equity Investor bij Brandon Capital Partners Pty Ltd.
Actieve functies van Roberto Solari
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Private Equity Investor | 01-01-2007 | - |
Loopbaan van Roberto Solari
Eerdere bekende functies van Roberto Solari
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Myricx Pharma Ltd.
Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Algemeen Directeur | 01-01-2019 | 15-11-2023 |
Voorzitter | 01-01-2019 | 15-11-2023 | |
Oprichter | 01-01-2019 | 15-11-2023 | |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | Voorzitter | 03-06-2015 | 30-04-2019 |
CalciCo Therapeutics Ltd.
CalciCo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology CalciCo Therapeutics Ltd. develops novel small molecule drugs for autoimmune and inflammatory disorders. The company was founded by Anant Parekh and is headquartered in Oxford, the United Kingdom. | Voorzitter | - | - |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Private Equity Analist | 01-02-2015 | - |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Directeur/Bestuurslid | 08-01-2015 | - |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Directeur/Bestuurslid | - | - |
Apax Partners Holdings Ltd.
Apax Partners Holdings Ltd. Financial ConglomeratesFinance Apax Partners Holdings Ltd. provides investment services. The firm focuses in the area of media, retail, health care, financial, and telecommunication sectors. The company was founded on February 6, 1991 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Oprichter | 17-08-2009 | - |
Corporate Officer/Principal | 01-01-1999 | 17-08-2009 |
Opleiding van Roberto Solari
The University of Nottingham | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 10 |
Verenigde Staten | 2 |
Operationeel
Chairman | 3 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 5 |
Finance | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 9 |
---|---|
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Apax Partners Holdings Ltd.
Apax Partners Holdings Ltd. Financial ConglomeratesFinance Apax Partners Holdings Ltd. provides investment services. The firm focuses in the area of media, retail, health care, financial, and telecommunication sectors. The company was founded on February 6, 1991 and is headquartered in London, the United Kingdom. | Finance |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Finance |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Finance |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
CalciCo Therapeutics Ltd.
CalciCo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology CalciCo Therapeutics Ltd. develops novel small molecule drugs for autoimmune and inflammatory disorders. The company was founded by Anant Parekh and is headquartered in Oxford, the United Kingdom. | Health Technology |
Myricx Pharma Ltd.
Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Roberto Solari
- Ervaring